Marco R. Scipione

Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections

Yu Lin Wang, Marco R. Scipione, Yanina Dubrovskaya et al. · Antimicrobial Agents and Chemotherapy · 2013 · 127 citations · Full text

Sxt Monotherapies, Antimicrobial Susceptibility, Health Sciences +15

Risk Factors for Treatment Failure of Polymyxin B Monotherapy for Carbapenem-Resistant Klebsiella pneumoniae Infections

Yanina Dubrovskaya, Ting-Yi Chen, Marco R. Scipione et al. · Antimicrobial Agents and Chemotherapy · 2013 · 56 citations · Full text

Klebsiella Pneumoniae, Antimicrobial Chemotherapy, Antibiotic Resistance +17

Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i>

Sara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette et al. · Open Forum Infectious Diseases · 2021 · 51 citations · Full text

Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii

Sara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf et al. · Microbiology Spectrum · 2022 · 38 citations · Full text

Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022

Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas et al. · Microbiology Spectrum · 2023 · 27 citations · Full text